Search Results - "Karpanen, Tarja J."

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Clinical evaluation of a chlorhexidine intravascular catheter gel dressing on short-term central venous catheters by Karpanen, Tarja J., PhD, Casey, Anna L., PhD, Whitehouse, Tony, FRCA, Nightingale, Peter, PhD, Das, Ira, FRCPath, Elliott, Thomas S.J., DSc

    “…Background A major source of microbial colonization of short-term central venous catheters (CVC) is the patients' endogenous skin microorganisms located at the…”
    Get full text
    Journal Article
  2. 2

    A clinical evaluation of two central venous catheter stabilization systems by Karpanen, Tarja J., Casey, Anna L., Whitehouse, Tony, Timsit, Jean-Francois, Mimoz, Olivier, Palomar, Mercedes, Elliott, Tom S. J.

    Published in Annals of intensive care (17-04-2019)
    “…Background Central venous catheters (CVCs) are commonly secured with sutures which are associated with microbial colonization and infection. We report a…”
    Get full text
    Journal Article
  3. 3

    An in vitro comparison of standard cleaning to a continuous passive disinfection cap for the decontamination of needle-free connectors by Casey, Anna L, Karpanen, Tarja J, Nightingale, Peter, Elliott, Tom S J

    “…The optimal decontamination method for needle-free connectors is still unresolved. The objective of this study was to determine if a continuous passive…”
    Get full text
    Journal Article
  4. 4

    Enhanced chlorhexidine skin penetration with eucalyptus oil by Karpanen, Tarja J, Conway, Barbara R, Worthington, Tony, Hilton, Anthony C, Elliott, Tom S J, Lambert, Peter A

    Published in BMC infectious diseases (22-09-2010)
    “…Chlorhexidine digluconate (CHG) is a widely used skin antiseptic, however it poorly penetrates the skin, limiting its efficacy against microorganisms residing…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Effectiveness of Disinfecting Caps for Intravenous Access Points in Reducing Central Line-Associated Bloodstream Infections, Clinical Utilization, and Cost of Care During COVID-19 by Hou, Yuefeng, Griffin, Leah P, Ertmer, Kari, Bernatchez, Stéphanie F, Kärpänen, Tarja J, Palka-Santini, Maria

    Published in ClinicoEconomics and outcomes research (01-01-2023)
    “…Intravenous (IV) access point protectors, serving as passive disinfection devices and a cover between line accesses, are available to help reduce the risk of…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Antimicrobial activity of a chlorhexidine intravascular catheter site gel dressing by Karpanen, Tarja J., Casey, Anna L., Conway, Barbara R., Lambert, Peter A., Elliott, Tom S. J.

    Published in Journal of antimicrobial chemotherapy (01-08-2011)
    “…Objectives The antimicrobial efficacy of a chlorhexidine gluconate (CHG) intravascular catheter gel dressing was evaluated against methicillin-resistant…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Studies of skin antisepsis and enhanced penetration of chlorhexidine by Kärpänen, Tarja J

    Published 01-01-2008
    “…Current evidence-based guidelines recommend that 2% (w/v) chlorhexidine digluconate (CHG), preferentially in 70% (v/v) isopropyl alcohol (IIPA), is used for…”
    Get full text
    Dissertation
  11. 11

    Studies of skin antisepsis and enhanced penetration of chlorhexidine by Kärpänen, Tarja J

    Published 01-01-2008
    “…Current evidence-based guidelines recommend that 2% (w/v) chlorhexidine digluconate (CHG), preferentially in 70% (v/v) isopropyl alcohol (IIPA), is used for…”
    Get full text
    Dissertation